Incruse Ellipta and Novoeight
Determining the interaction of Incruse Ellipta and Novoeight and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Novoeight recombinant
- Incruse Ellipta-Novolin 70/30
- Incruse Ellipta-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Incruse Ellipta-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Incruse Ellipta-Novolin N
- Incruse Ellipta-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Novoeight-Indacaterol
- Novoeight-Indacaterol and Glycopyrrolate
- Novoeight-Indacaterol and glycopyrrolate Inhalation
- Novoeight-Indacaterol inhalation
- Novoeight-Indacaterol Maleate
- Novoeight-Indapamide